Patient Safety

Safety Matters at Lilly

Beginning with the discovery of a potential new medicine, and for as long as it is available to patients, our goal is to ensure that the benefits and risks of a medication are continuously monitored and well-understood by regulators, health care providers and patients.

Lilly maintains a pharmacovigilance system, collecting data throughout the lifecycle of each product. This system is designed to continually maintain and evaluate the product's benefit/risk profile. When important safety issues arise, Lilly communicates them to doctors, patients and regulatory agencies.

two people walking along path in Lilly courtyard

How to report an adverse event

Learn More

Vials with orange and purple caps in ice


Learn More

PP-MG-NZ-0019 02/2024